Old Web
English
Sign In
Acemap
>
authorDetail
>
Zhengyi Yin
Zhengyi Yin
Ruxolitinib
Bone marrow
Immunology
Medicine
Stromal cell
4
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Ruxolitinib reverses checkpoint inhibition by reducing programmed cell death ligand-1 (PD-L1) expression and increases anti-tumour effects of T cells in multiple myeloma
2020
British Journal of Haematology
Haiming Chen
Mingjie Li
Nicole Ng
Erin Yu
Sean Bujarski
Zhengyi Yin
Mingxiang Wen
Tara Hekmati
Dylan Field
Jasper Wang
Isabella Nassir
Janna Yu
Justin Huang
David Daniely
Cathy S Wang
Ning Xu
Tanya M. Spektor
James R. Berenson
Show All
Source
Cite
Save
Citations (3)
The JAK1/2 Inhibitor Ruxolitinib Downregulates CXCL12 Secretion from Bone Marrow Stromal Cells and M2 Macrophage Polarization in Multiple Myeloma
2019
Blood
Haiming Chen
Mingjie Li
Eric Sanchez
Nicole Ng
Erin Yu
Sean Bujarski
Zhengyi Yin
Tara Hekmati
Dylan Field
Jasper Wang
Isabella Nassir
Justin Huang
David Daniely
Cathy S Wang
Ning Xu
James R. Berenson
Show All
Source
Cite
Save
Citations (0)
The JAK1/2 Inhibitor Ruxolitinib Downregulates the Immune Checkpoint Protein B7-H3 in Multiple Myeloma
2019
Blood
Ning Xu
Nicole Ng
Mingjie Li
Erin Yu
Eric Sanchez
Sean Bujarski
Zhengyi Yin
Tara Hekmati
Dylan Field
Jasper Wang
Isabella Nassir
Janna Yu
Justin Huang
David Daniely
Cathy S Wang
Haiming Chen
James R. Berenson
Show All
Source
Cite
Save
Citations (0)
Ruxolitinib Reverses Checkpoint Inhibition By Downregulating PD-L1 and PD-L2 Expression on Both Tumor and Stromal Cells in Multiple Myeloma
2019
Blood
Haiming Chen
Mingjie Li
Eric Sanchez
Nicole Ng
Erin Yu
Sean Bujarski
Zhengyi Yin
Tara Hekmati
Dylan Field
Jasper Wang
Isabella Nassir
Janna Yu
Justin Huang
David Daniely
Cathy S Wang
Ning Xu
James R. Berenson
Show All
Source
Cite
Save
Citations (0)
1